Obesity drug developer Kalohexis files confidentially for U.S. IPO
Covered by 2 sources · 2 articles
2 outlets - including Yahoo and Seekingalpha - are covering this story.
Covered by
Covered by 2 sources · 2 articles
2 outlets - including Yahoo and Seekingalpha - are covering this story.